Amicus Therapeutics to Present at Upcoming Investor Conferences in September 2020

Rhea-AI Summary

Amicus Therapeutics (Nasdaq: FOLD) announced its senior leadership team's participation in three virtual investor conferences in September 2020. Events include Citi's 15th Annual BioPharma Virtual Conference on September 10 at 8:55 a.m. E.T., Cantor Virtual Global Healthcare Conference on September 16 at 10:00 a.m. E.T., and Bank of America Global Healthcare Conference on September 18 at 4:45 p.m. B.S.T. Live audio webcasts can be accessed via the company's Investors section on their website.

Amicus focuses on developing innovative treatments for rare metabolic diseases.

CRANBURY, N.J., Sept. 03, 2020 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that members of the Amicus senior leadership team will participate in upcoming presentations at the following virtual investor conferences in September:

• Citi’s 15^th Annual BioPharma Virtual Conference on Thursday, September 10, 2020 at 8:55 a.m. E.T.
• Cantor Virtual Global Healthcare Conference on Wednesday, September 16, 2020 at 10:00 a.m. E.T.
• Bank of America Global Healthcare Conference on Friday, September 18, 2020 at 4:45 p.m. B.S.T. (11:45 a.m. E.T.)

A live audio webcast of each presentation can be accessed via the Investors section of the Amicus Therapeutics corporate website at https://ir.amicusrx.com/events-and-presentations.

About Amicus Therapeutics
Amicus Therapeutics (Nasdaq: FOLD) is a global, patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare metabolic diseases. With extraordinary patient focus, Amicus Therapeutics is committed to advancing and expanding a robust pipeline of cutting-edge, first- or best-in-class medicines for rare metabolic diseases. For more information please visit the company’s website at www.amicusrx.com, and follow on Twitter and LinkedIn.

Investors:
Amicus Therapeutics
Andrew Faughnan
Director, Investor Relations
afaughnan@amicusrx.com
(609) 662-3809

Media:
Amicus Therapeutics
Diana Moore
Head of Global Corporate Communications
dmoore@amicusrx.com
(609) 662-5079

FOLD–G

FAQ

What dates will Amicus Therapeutics participate in investor conferences in September 2020?

Amicus Therapeutics will participate in the following conferences: Citi's 15th Annual BioPharma Virtual Conference on September 10 at 8:55 a.m. E.T., Cantor Virtual Global Healthcare Conference on September 16 at 10:00 a.m. E.T., and Bank of America Global Healthcare Conference on September 18 at 4:45 p.m. B.S.T.

How can I access the live webcasts of Amicus Therapeutics' presentations?

Live audio webcasts of Amicus Therapeutics' presentations can be accessed via the Investors section of the company's corporate website.

What is the focus of Amicus Therapeutics as a biotechnology company?

Amicus Therapeutics is dedicated to discovering, developing, and delivering high-quality medicines for individuals living with rare metabolic diseases.

What is the ticker symbol for Amicus Therapeutics?

The ticker symbol for Amicus Therapeutics is FOLD.

Who can I contact for investor relations at Amicus Therapeutics?

For investor relations at Amicus Therapeutics, you can contact Andrew Faughnan, Director of Investor Relations, at afaughnan@amicusrx.com.